Aten Porus Lifesciences: Financial Breakdown
Decoding financial health metrics of Aten Porus Lifesciences
Total Revenue₹24.2 Lakh-92%Prev. FY
Total Expenses₹3.1 Cr7%Prev. FY
Profit After Tax₹-2.9 Cr-1057%Prev. FY
Total Assets₹18.4 Cr-4%Prev. FY
FAQs on Financials of Aten Porus Lifesciences
No. In FY25, Aten Porus Lifesciences reported a net loss of ₹2.9 Cr, so it was not profitable.
Aten Porus Lifesciences's revenue declined 91.0% year-on-year, from ₹2.7 Cr in FY24 to ₹24.2 Lakh in FY25.
Aten Porus Lifesciences's estimated EBITDA for FY25 was ₹-2.4 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Aten Porus Lifesciences posted revenue of ₹24.2 Lakh (down 91.0% YoY) and a net loss of ₹2.9 Cr. Explore the full financials of Aten Porus Lifesciences here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links